tiprankstipranks
Advertisement
Advertisement

APVO Stock Latest News

Aptevo Therapeutics Secures Grant for APVO451 Development
Company AnnouncementsAptevo Therapeutics Secures Grant for APVO451 Development
20d ago
8K
APVO
Aptevo Therapeutics awarded $1.5M research grant from Andy Hill CARE Fund
PremiumThe Fly
Aptevo Therapeutics awarded $1.5M research grant from Andy Hill CARE Fund
21d ago
APVO
Aptevo Therapeutics appoints Janatpour as SVP, CSO
PremiumThe Fly
Aptevo Therapeutics appoints Janatpour as SVP, CSO
2M ago
APVO
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
PremiumCompany Announcements
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
2M ago
8K
APVO
Aptevo, Niowave launch collab for radiopharmaceutical oncology programs
PremiumThe Fly
Aptevo, Niowave launch collab for radiopharmaceutical oncology programs
2M ago
APVO
Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
PremiumThe FlyAptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
2M ago
APVO
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
Premium
The Fly
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
2M ago
APVO
Aptevo Highlights Strong Phase 1b AML Trial Results
Premium
Company Announcements
Aptevo Highlights Strong Phase 1b AML Trial Results
3M ago
8K
APVO
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
PremiumThe Fly
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
4M ago
APVO
Aptevo Therapeutics sees cash runway into 4Q26
PremiumThe Fly
Aptevo Therapeutics sees cash runway into 4Q26
4M ago
APVO
Aptevo Reports Promising Interim Data for AML Therapy
PremiumCompany Announcements
Aptevo Reports Promising Interim Data for AML Therapy
4M ago
8K
APVO
Aptevo Therapeutics announces interim data for mipletamig combination
PremiumThe Fly
Aptevo Therapeutics announces interim data for mipletamig combination
4M ago
APVO
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
PremiumCompany AnnouncementsAptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
5M ago
8K
APVO
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
Premium
Company Announcements
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
6M ago
8K
APVO
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
Premium
The Fly
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
6M ago
APVO
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
PremiumThe Fly
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
6M ago
APVO
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
PremiumCompany Announcements
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
6M ago
8K
APVO
Aptevo Therapeutics secures $60M equity line of credit
PremiumThe Fly
Aptevo Therapeutics secures $60M equity line of credit
6M ago
APVO
Aptevo Therapeutics trading halted, news pending
PremiumThe Fly
Aptevo Therapeutics trading halted, news pending
7M ago
APVO
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
PremiumCompany AnnouncementsAptevo Therapeutics Implements 1-for-18 Reverse Stock Split
7M ago
8K
APVO
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
7M ago
WOK
ACET
Aptevo Therapeutics Announces Promising RAINIER Trial Results
Premium
Company Announcements
Aptevo Therapeutics Announces Promising RAINIER Trial Results
7M ago
8K
APVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >